ALOX5 and asthma: Zileuton inhibits the enzymatic activity of 5-LOX and triggers the above-mentioned reactions by reducing the downstream production of 5-LOX products (e.g., LTB4, LTC4, LTD4, and LTE4), thereby achieving a therapeutic effect against asthma [18].